Delfim Duarte, MD PhD
Instituto de Investigação e Inovação em Saúde da Universidade do Porto, Portugal
Cell competition as a mechanism to eliminate minimal residual disease in acute myeloid leukemia
Amy Erbe-Gurel, PhD
University of Wisconsin
Improving Specific Targeting of Neuroblastoma Tumors through Bispecific SNIPER Antibody to Reduce Off-Target Toxicities
Dung-Fang Lee, PhD
The University of Texas Health Science Center
The Epitranscriptomic Pathway is a Therapeutic Vulnerability in p53-mutant Osteosarcoma
Vicki Huff, PhD
University of Texas M.D. Anderson Cancer Center
Assessment of a cancer preventive agent for Wilms tumor
Thais Armangue, MD, PhD
Institute for Biomedical Research August Pi i Sunyer-Barcelona, Spain
Opsoclonus myoclonus syndrome: a novel approach to antigen identification and disease modeling
Grant Funded in Partnership with The Viswanatha Family + Friends
Julien Fleurence PhD, PharmD
Baylor College of Medicine
T cells expressing a next-generation glypican-3-specific CAR incorporating IL-7 receptor signaling to cure pediatric liver cancers
Lai Man (Natalie) Wu , PhD
Cincinnati Children’s Hospital Medical Center
Identification of cellular diversity and tumor-initiating cells driving NF-to-MPNST and drug resistance by single-cell multiomics for targeted therapy
Supported in part by Hanna's Hoops 4 Healing
Alexandra Stevens, MD, PhD
Baylor College of Medicine
Predicting Atovaquone-Induced Apoptosis in Pediatric AML
Grant Rowe, MD PhD
Children’s Hospital Boston
Targeting leukemia stem cells in infant B-lymphoblastic leukemia
This grant is funded by Change a Life Foundation
Laura Perin, PhD
Children's Hospital Los Angeles
Cancer Stem Cells in Wilms Tumor: Can the Self-Renewal State Be Pushed to Nephrogenesis?
Surinder Kumar, PhD
University of Michigan
The sirtuin SIRT5 as a novel therapeutic target for Ewing's Sarcoma
This grant is funded by Peloton Magazine
Kathryn Lemberg, md, phd
Johns Hopkins University - School of Medicine
Investigating novel glutamine antagonists as a therapeutic strategy for malignant peripheral nerve sheath tumors
W. Clay Gustafson, md, phd
University of California San Francisco
Drugging the Aurora Kinase A Interactome in Neuroblastoma
Joanna Gell, md
University of California Los Angeles
Utilizing Pluripotent Stem Cells to Evaluate the Role KIT and KRAS Play in Germ Cell Development and Tumorigenesis
Masanori Hayashi, MD
John Hopkins Universtiy
Identification and targeting of circulating Ewing sarcoma stem cells
Jessica L. Heath, MD
University of Vermont
Critical Contributions of CRM1 to Pediatric Leukemogenesis.
Andras Heczey, M.D.
Texas Children's Hospital, Baylor College of Medicine
Glypican-3 specific T-cells for the adoptive immunotherapy of pediatric liver cancers
Christopher Ott, Ph.D.
Massachusetts General Hospital
Discovery of Epigenetic Factors Essential for T Cell Leukemia